Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022

Authors: Kim, Sara S., Chung, Jessie R., Talbot, H. Keipp, Grijalva, Carlos G., Wernli, Karen J., Kiniry, Erika, Martin, Emily T., Monto, Arnold S., Belongia, Edward A., McLean, Huong Q., Gaglani, Manjusha, Mamawala, Mufaddal, Nowalk, Mary Patricia, Moehling Geffel, Krissy, Tartof, Sara Y., Florea, Ana, Lee, Justin S., Tenforde, Mark W., Patel, Manish M., Flannery, Brendan, Bentz, Meghan L., Burgin, Alex, Burroughs, Mark, Davis, Morgan L., Howard, Dakota, Lacek, Kristine, Madden, Joseph C., Nobles, Sarah, Padilla, Jasmine, Sheth, Mili

Source: Influenza and other respiratory viruses. 16(6):975-985

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190083197.0x000001&indx=1&recIds=ETOCvdc_100190083197.0x000001

SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.

Authors: Lacek, Kristine A.¹, Rambo-Martin, Benjamin L.¹, Batra, Dhwani¹, Xiao-yu Zheng^1,2, Hassell, Norman¹, Sakaguchi, Hitoshi³, Peacock, Thomas^4,5, Groves, Natalie⁴, Keller, Matthew¹, Wilson, Malania M.¹, Sheth, Mili¹, Davis, Morgan L.^1,6, Borroughs, Mark¹, Gerhart, Jonathan^1,6, Shepard, Samuel S.¹, Cook, Peter W.¹, Lee, Justin¹, Wentworth, David E.¹, Barnes, John R.¹, Kondor, Rebecca¹

Source: Emerging Infectious Diseases. Jul2022, Vol. 28 Issue 7, p1442-1445. 4p.

Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves.

Authors: Di, Han, Pusch, Elizabeth A., Jones, Joyce, Kovacs, Nicholas A., Hassell, Norman, Sheth, Mili, Lynn, Kelly Sabrina, Keller, Matthew W., Wilson, Malania M., Keong, Lisa M., Cui, Dan, Park, So Hee, Chau, Reina, Lacek, Kristine A., Liddell, Jimma D., Kirby, Marie K., Yang, Genyan, Johnson, Monique, Thor, Sharmi, Zanders, Natosha

Source: Vaccines; May2024, Vol. 12 Issue 5, p505, 18p

Subject Terms: SARS-CoV-2, SARS-CoV-2 Omicron variant, SARS-CoV-2 Delta variant

Company/Entity: CENTERS for Disease Control & Prevention (U.S.)

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023.

Authors: Ma, Kevin C., Shirk, Philip, Lambrou, Anastasia S., Hassell, Norman, Xiao-yu Zheng, Payne, Amanda B., Ali, Akilah R., Batra, Dhwani, Caravas, Jason, Chau, Reina, Cook, Peter W., Howard, Dakota, Kovacs, Nicholas A., Lacek, Kristine A., Lee, Justin S., MacCannell, Duncan R., Malapati, Lakshmi, Mathew, Sandra, Mittal, Neha, Nagilla, Roopa R.

Source: MMWR: Morbidity & Mortality Weekly Report; 6/16/2023, Vol. 72 Issue 24, p651-656, 6p, 1 Chart, 1 Graph, 1 Map

Subject Terms: SARS disease, CORONAVIRUS diseases, RESPIRATORY infections, SARS-CoV-2 Omicron variant, PUBLIC health

Canalization and Robustness in Human Genetics and Disease.

Authors: Gibson, Greg¹ (AUTHOR) greg.gibson@biology.gatech.edu, Lacek, Kristine A.¹ (AUTHOR)

Source: Annual Review of Genetics. Nov2020, Vol. 54, p189-211. 20p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.